PFM Health Sciences’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,405,056
| Closed | -$25.2M | – | 73 |
|
|
2023
Q3 | $25.2M | Hold |
1,405,056
| – | – | 1.19% | 37 |
|
|
2023
Q2 | $28.5M | Sell |
1,405,056
-154,891
| -10% | -$3.15M | 1.11% | 39 |
|
|
2023
Q1 | $28.5M | Sell |
1,559,947
-1,143,340
| -42% | -$20.9M | 1.26% | 34 |
|
|
2022
Q4 | $55.9M | Sell |
2,703,287
-679,946
| -20% | -$14.1M | 2% | 9 |
|
|
2022
Q3 | $88.5M | Buy |
3,383,233
+36,775
| +1% | +$962K | 3.2% | 4 |
|
|
2022
Q2 | $84.8M | Sell |
3,346,458
-84,552
| -2% | -$2.14M | 3.23% | 8 |
|
|
2022
Q1 | $108M | Hold |
3,431,010
| – | – | 4.05% | 3 |
|
|
2021
Q4 | $139M | Hold |
3,431,010
| – | – | 4.73% | 1 |
|
|
2021
Q3 | $120M | Sell |
3,431,010
-67,250
| -2% | -$2.35M | 3.52% | 4 |
|
|
2021
Q2 | $96.1M | Hold |
3,498,260
| – | – | 3.01% | 7 |
|
|
2021
Q1 | $98.2M | Buy |
3,498,260
+124,800
| +4% | +$3.5M | 3% | 6 |
|
|
2020
Q4 | $87.6M | Buy |
3,373,460
+836,528
| +33% | +$21.7M | 3.08% | 5 |
|
|
2020
Q3 | $43.5M | Buy |
2,536,932
+801,351
| +46% | +$13.7M | 2.01% | 13 |
|
|
2020
Q2 | $42.9M | Buy |
1,735,581
+926,070
| +114% | +$22.9M | 2.23% | 11 |
|
|
2020
Q1 | $11.2M | Buy |
+809,511
| New | +$11.2M | 0.92% | 38 |
|
|
2019
Q1 | – | Sell |
-220,976
| Closed | -$2.38M | – | 107 |
|
|
2018
Q4 | $2.38M | Sell |
220,976
-502,858
| -69% | -$5.42M | 0.06% | 80 |
|
|
2018
Q3 | $10.1M | Sell |
723,834
-44,445
| -6% | -$620K | 0.15% | 95 |
|
|
2018
Q2 | $9.4M | Sell |
768,279
-165,007
| -18% | -$2.02M | 0.15% | 92 |
|
|
2018
Q1 | $14.4M | Buy |
+933,286
| New | +$14.4M | 0.29% | 77 |
|